↓ Skip to main content

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis

Overview of attention for article published in Frontiers in oncology, August 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
Published in
Frontiers in oncology, August 2022
DOI 10.3389/fonc.2022.867356
Pubmed ID
Authors

Michael Stadler, Letizia Venturini, Ivonne Bünting, Elke Dammann, Eva M Weissinger, Adrian Schwarzer, Christian Schultze-Florey, Steve Ehrlich, Dominik Markel, Catherina Lueck, Alexandra Gladysz, Tabea Fröhlich, Nouraldin Damrah, Gernot Beutel, Matthias Eder, Arnold Ganser, Lothar Hambach

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 1 17%
Student > Master 1 17%
Unknown 4 67%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Sports and Recreations 1 17%
Unknown 3 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2022.
All research outputs
#21,310,332
of 26,169,168 outputs
Outputs from Frontiers in oncology
#11,651
of 22,913 outputs
Outputs of similar age
#323,554
of 436,408 outputs
Outputs of similar age from Frontiers in oncology
#985
of 1,811 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,408 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,811 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.